Di Perri G - Search Results

1

Di Perri G. Di Perri G. Infez Med. 2020 Dec 1;28(4):525-533. Infez Med. 2020. PMID: 33257626 Free article.

2

A new assay based on solid-phase extraction procedure with LC-MS to measure plasmatic concentrations of tenofovir and emtricitabine in HIV infected patients.

D'Avolio A, Sciandra M, Siccardi M, Baietto L, Gonzalez de Requena D, Bonora S, Di Perri G. D'Avolio A, et al. Among authors: di perri g. J Chromatogr Sci. 2008 Jul;46(6):524-8. doi: 10.1093/chromsci/46.6.524. J Chromatogr Sci. 2008. PMID: 18647474

3

[HIV infection: treatment of naive patients].

Bonora S, Calcagno A, Di Perri G. Bonora S, et al. Among authors: di perri g. Infez Med. 2009 Jun;17(2):69-81. Infez Med. 2009. PMID: 19602919 Free article. Review. Italian.

4

Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations.

Rodríguez-Nóvoa S, Labarga P, D'avolio A, Barreiro P, Albalate M, Vispo E, Solera C, Siccardi M, Bonora S, Di Perri G, Soriano V. Rodríguez-Nóvoa S, et al. Among authors: di perri g. AIDS. 2010 Apr 24;24(7):1064-6. doi: 10.1097/QAD.0b013e32833202e2. AIDS. 2010. PMID: 20299966

5

Pharmacokinetics of switching unboosted atazanavir coadministered with tenofovir disoproxil fumarate from 400 mg once daily to 200 mg twice daily in HIV-positive patients.

Bonora S, Gonzalez de Requena D, D'Avolio A, Calcagno A, Tettoni M, Siccardi M, Baietto L, Simiele M, Trentini L, Di Perri G. Bonora S, et al. Among authors: di perri g. Antivir Ther. 2011;16(4):499-504. doi: 10.3851/IMP1802. Antivir Ther. 2011. PMID: 21685537

6

Anidulafungin versus fluconazole: clinical focus on IDSA and ESCMID guidelines.

De Rosa FG, Motta I, Corcione S, Cattel F, Di Perri G, D'Avolio A. De Rosa FG, et al. Among authors: di perri g. Infez Med. 2014 Jun;22(2):107-11. Infez Med. 2014. PMID: 24955796 Free article. Review.

7

A LC-MS method to quantify tenofovir urinary concentrations in treated patients.

Simiele M, Carcieri C, De Nicolò A, Ariaudo A, Sciandra M, Calcagno A, Bonora S, Di Perri G, D'Avolio A. Simiele M, et al. Among authors: di perri g. J Pharm Biomed Anal. 2015 Oct 10;114:8-11. doi: 10.1016/j.jpba.2015.05.001. Epub 2015 May 8. J Pharm Biomed Anal. 2015. PMID: 25997174

8

Candidemia, and infections by Clostridium difficile and carbapenemase-producing Enterobacteriaceae: new enteropathogenetic opportunistic syndromes?

De Rosa FG, Corcione S, Raviolo S, Montrucchio C, Aldieri C, Pagani N, Di Perri G. De Rosa FG, et al. Among authors: di perri g. Infez Med. 2015 Jun;23(2):105-16. Infez Med. 2015. PMID: 26110290 Free article. Review.

9

Wound botulism after traumatic open fracture in Italy.

De Rosa FG, Stella ML, Astegiano S, Corcione S, Motta I, Decastelli L, Di Perri G. De Rosa FG, et al. Among authors: di perri g. Infez Med. 2015 Sep;23(3):280-2. Infez Med. 2015. PMID: 26397301 Free article.

10

Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study.

Mills A, Arribas JR, Andrade-Villanueva J, DiPerri G, Van Lunzen J, Koenig E, Elion R, Cavassini M, Madruga JV, Brunetta J, Shamblaw D, DeJesus E, Orkin C, Wohl DA, Brar I, Stephens JL, Girard PM, Huhn G, Plummer A, Liu YP, Cheng AK, McCallister S; GS-US-292-0109 team. Mills A, et al. Lancet Infect Dis. 2016 Jan;16(1):43-52. doi: 10.1016/S1473-3099(15)00348-5. Epub 2015 Nov 2. Lancet Infect Dis. 2016. PMID: 26538525 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

717 results

Search Page